SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-110850
Filing Date
2024-10-23
Accepted
2024-10-23 16:01:44
Documents
10
Period of Report
2024-10-23

Document Format Files

Seq Description Document Type Size
1 6-K tm2426281-1_6k.htm 6-K 15031
2 EXHIBIT 99.1 tm2426281d1_exh99x1.htm EX-99.1 1158801
3 EXHIBIT 99.2 tm2426281d1_exh99x2.htm EX-99.2 11490
4 EXHIBIT 99.3 tm2426281d1_exh99x3.htm EX-99.3 8626
5 GRAPHIC ft_praxity-bwlr.jpg GRAPHIC 11568
6 GRAPHIC lg_mnp-bwlr.jpg GRAPHIC 2817
7 GRAPHIC lg_psycencebiomed-bwlr.jpg GRAPHIC 20373
8 GRAPHIC sg_mnpllp-bw.jpg GRAPHIC 2729
9 GRAPHIC px_24psyencepy01pg01-bw.jpg GRAPHIC 323834
10 GRAPHIC px_24psyencepy01pg02-bw.jpg GRAPHIC 490894
  Complete submission text file 0001104659-24-110850.txt   2341680
Mailing Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1
Business Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1 27744604171
PSYENCE BIOMEDICAL LTD. (Filer) CIK: 0001985062 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-41937 | Film No.: 241389207
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)